337 related articles for article (PubMed ID: 9092813)
1. Chemical synthesis, structural modeling, and biological activity of the epidermal growth factor-like domain of human cripto.
Lohmeyer M; Harrison PM; Kannan S; DeSantis M; O'Reilly NJ; Sternberg MJ; Salomon DS; Gullick WJ
Biochemistry; 1997 Apr; 36(13):3837-45. PubMed ID: 9092813
[TBL] [Abstract][Full Text] [Related]
2. Structural insights into the interaction between the Cripto CFC domain and the ALK4 receptor.
Calvanese L; Saporito A; Oliva R; D' Auria G; Pedone C; Paolillo L; Ruvo M; Marasco D; Falcigno L
J Pept Sci; 2009 Mar; 15(3):175-83. PubMed ID: 19035567
[TBL] [Abstract][Full Text] [Related]
3. Chemical synthesis of mouse cripto CFC variants.
Marasco D; Saporito A; Ponticelli S; Chambery A; De Falco S; Pedone C; Minchiotti G; Ruvo M
Proteins; 2006 Aug; 64(3):779-88. PubMed ID: 16752415
[TBL] [Abstract][Full Text] [Related]
4. Structure and function of the epidermal growth factor domain of P-selectin.
Freedman SJ; Sanford DG; Bachovchin WW; Furie BC; Baleja JD; Furie B
Biochemistry; 1996 Oct; 35(43):13733-44. PubMed ID: 8901515
[TBL] [Abstract][Full Text] [Related]
5. Detection and localization of Cripto-1 binding in mouse mammary epithelial cells and in the mouse mammary gland using an immunoglobulin-cripto-1 fusion protein.
Bianco C; Normanno N; De Luca A; Maiello MR; Wechselberger C; Sun Y; Khan N; Adkins H; Sanicola M; Vonderhaar B; Cohen B; Seno M; Salomon D
J Cell Physiol; 2002 Jan; 190(1):74-82. PubMed ID: 11807813
[TBL] [Abstract][Full Text] [Related]
6. The chemical synthesis and binding affinity to the EGF receptor of the EGF-like domain of heparin-binding EGF-like growth factor (HB-EGF).
Shin SY; Yokoyama T; Takenouchi T; Munekata E
J Pept Sci; 2003 Apr; 9(4):244-50. PubMed ID: 12725245
[TBL] [Abstract][Full Text] [Related]
7. Cripto-1 inhibits beta-casein expression in mammary epithelial cells through a p21ras-and phosphatidylinositol 3'-kinase-dependent pathway.
De Santis ML; Kannan S; Smith GH; Seno M; Bianco C; Kim N; Martinez-Lacaci I; Wallace-Jones B; Salomon DS
Cell Growth Differ; 1997 Dec; 8(12):1257-66. PubMed ID: 9419414
[TBL] [Abstract][Full Text] [Related]
8. Entropic folding pathway of human epidermal growth factor explored by disulfide scrambling and amplified collective motion simulations.
Zhang Z; Boyle PC; Lu BY; Chang JY; Wriggers W
Biochemistry; 2006 Dec; 45(51):15269-78. PubMed ID: 17176049
[TBL] [Abstract][Full Text] [Related]
9. Calcium binding properties of an epidermal growth factor-like domain from human thrombomodulin.
Tolkatchev D; Ni F
Biochemistry; 1998 Jun; 37(25):9091-100. PubMed ID: 9636055
[TBL] [Abstract][Full Text] [Related]
10. The role of disulfide bonds in the structure and function of murine epidermal growth factor (mEGF).
Alewood D; Nielsen K; Alewood PF; Craik DJ; Andrews P; Nerrie M; White S; Domagala T; Walker F; Rothacker J; Burgess AW; Nice EC
Growth Factors; 2005 Jun; 23(2):97-110. PubMed ID: 16019431
[TBL] [Abstract][Full Text] [Related]
11. Solution structure of mouse Cripto CFC domain and its inactive variant Trp107Ala.
Calvanese L; Saporito A; Marasco D; D'Auria G; Minchiotti G; Pedone C; Paolillo L; Falcigno L; Ruvo M
J Med Chem; 2006 Nov; 49(24):7054-62. PubMed ID: 17125258
[TBL] [Abstract][Full Text] [Related]
12. Expression of teratocarcinoma-derived growth factor-1 (TDGF-1) in testis germ cell tumors and its effects on growth and differentiation of embryonal carcinoma cell line NTERA2/D1.
Baldassarre G; Romano A; Armenante F; Rambaldi M; Paoletti I; Sandomenico C; Pepe S; Staibano S; Salvatore G; De Rosa G; Persico MG; Viglietto G
Oncogene; 1997 Aug; 15(8):927-36. PubMed ID: 9285688
[TBL] [Abstract][Full Text] [Related]
13. Neuroblastoma angiogenesis is inhibited with a folded synthetic molecule corresponding to the epidermal growth factor-like module of the follistatin domain of SPARC.
Chlenski A; Liu S; Baker LJ; Yang Q; Tian Y; Salwen HR; Cohn SL
Cancer Res; 2004 Oct; 64(20):7420-5. PubMed ID: 15492265
[TBL] [Abstract][Full Text] [Related]
14. The CRIPTO/FRL-1/CRYPTIC (CFC) domain of human Cripto. Functional and structural insights through disulfide structure analysis.
Foley SF; van Vlijmen HW; Boynton RE; Adkins HB; Cheung AE; Singh J; Sanicola M; Young CN; Wen D
Eur J Biochem; 2003 Sep; 270(17):3610-8. PubMed ID: 12919325
[TBL] [Abstract][Full Text] [Related]
15. Structural investigations on the Nodal-Cripto binding: a theoretical and experimental approach.
Calvanese L; Marasco D; Doti N; Saporito A; D'Auria G; Paolillo L; Ruvo M; Falcigno L
Biopolymers; 2010 Nov; 93(11):1011-21. PubMed ID: 20629020
[TBL] [Abstract][Full Text] [Related]
16. Cripto: a novel target for antibody-based cancer immunotherapy.
Xing PX; Hu XF; Pietersz GA; Hosick HL; McKenzie IF
Cancer Res; 2004 Jun; 64(11):4018-23. PubMed ID: 15173016
[TBL] [Abstract][Full Text] [Related]
17. Cripto-1 enhances migration and branching morphogenesis of mouse mammary epithelial cells.
Wechselberger C; Ebert AD; Bianco C; Khan NI; Sun Y; Wallace-Jones B; Montesano R; Salomon DS
Exp Cell Res; 2001 May; 266(1):95-105. PubMed ID: 11339828
[TBL] [Abstract][Full Text] [Related]
18. NMR structure and backbone dynamics of a concatemer of epidermal growth factor homology modules of the human low-density lipoprotein receptor.
Kurniawan ND; Aliabadizadeh K; Brereton IM; Kroon PA; Smith R
J Mol Biol; 2001 Aug; 311(2):341-56. PubMed ID: 11478865
[TBL] [Abstract][Full Text] [Related]
19. Solution structure of the epidermal growth factor (EGF)-like module of human complement protease C1r, an atypical member of the EGF family.
Bersch B; Hernandez JF; Marion D; Arlaud GJ
Biochemistry; 1998 Feb; 37(5):1204-14. PubMed ID: 9477945
[TBL] [Abstract][Full Text] [Related]
20. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
